Although officially banned for human consumption by the FDA, alkyl nitrites — commonly known as poppers — have been sold ...

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

The ports of LA and Long Beach are the biggest sources of air pollution in the LA basin. Air quality officials have drafted ...

Annual increase of 0.24 percentage points seen in children aged 5 to 17 years and of 0.33 percentage points for young adults age 18 to 25 years ...

Nearly 3 out of every 4 older Americans have experienced at least one extreme weather event in the last two years, a poll finds. And living through such an event appears to make a big difference in ...

Tony Murphy was a solid 20-a-day smoker. His attempts at quitting lasted at best days, often only hours, as his craving for a ...

France Insoumise has made international headlines for almost a decade, as the leading force on the country’s left. Until its ...

GUTHRIE CENTER - GCH Specialty Clinic is pleased to announce the expansion of its healthcare services to include allergy, asthma, and immunology care, in collaboration with Iowa Allergy, Asthma, and ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction options for adults with moderate to severe active Crohn disease.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...